IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION
Case Number:
2:16-md-02724
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Sarraf Gentile
- Burns Charest
- Andrus Anderson
- McCune Law
- Patterson Belknap
- Gustafson Gluek
- Fiddler Gonzalez
- Obermayer Rebmann
- Ahern and Associates
- Goodwin Procter
- Spiro Harrison
- Harkins Cunningham
- Axinn Veltrop
- McDermott Will & Schulte
- Royer Cooper
- Armstrong Teasdale
- Levin Sedran
- Tostrud Law Group
- NastLaw
- Gross & Belsky
- Kabat Chapman
- Lowenstein Sandler
- Tycko & Zavareei
- Skadden Arps
- Freedman Boyd
- Buchanan Ingersoll
- Earp Cohn
- Steyer Lowenthal
- Zelle LLP
- Cera LLP
- Garwin Gerstein
- Krantz & Berman
- Lockridge Grindal
- Edelson Lechtzin
- Grabar Law
- Rosenn Jenkins
- Barrack Rodos
- Pogust Goodhead
- Anselmi & Carvelli
- Saiber LLC
- Cuneo Gilbert
- K&L Gates
- Welsh & Recker
- DeCotiis FitzPatrick
- Berry Law LLC
- Motley Rice
- Pendley Baudin
- Zwerling Schachter
- Joseph Saveri Law Firm
- Competition Law Partners
- Faegre Drinker
- Morgan Lewis
- Seeger Weiss
- King & Spalding
- Steptoe LLP
- Larson King
- Winston & Strawn
- Barrett Law Group
- McConnell Valdes
- Safirstein Law
- Stueve Siegel
- Robbins Geller
- Kelley Drye
- Neufeld Scheck
- WilmerHale
- Spector Roseman
- Venable LLP
- Neal & Harwell
- Vinson & Elkins
- Foley & Lardner
- Goldman Scarlato
- Heins Mills
- Hach Rose Schirripa
- Faruqi & Faruqi
- Greenberg Traurig
- Linklaters LLP
- Stevens & Lee
- Schertler Onorato
- Fenwick & West
- Baker Botts
- Segal McCambridge
- White & Case
- Wiggin & Dana
- Scott&Scott
- Shinder Cantor
- Stradley Ronon
- Crowell & Moring
- Blank Rome
- Kirkland & Ellis
- Wexler Boley
- Roberts Law Firm US
- Baker & Hostetler
- Duane Morris
- Freshfields
- Zuckerman Spaeder
- Kasowitz Benson
- White and Williams
- Walsh Pizzi
- Boni Zack
- Arnold & Porter
- Haynes Boone
- DLA Piper
- Girard Sharp
- Cole Schotz
- Hogan Lovells
- Fox Rothschild
- Sills Cummis
- Cleary Gottlieb
- Kohn Swift
- Norton Rose
- Williams & Connolly
- Lyden Chappell
- Morrison & Foerster
- Troutman
- Hagens Berman
- Bonsignore Trial Lawyers
- Cozen O'Connor
- Napoli Shkolnik
- Carella Byrne
- Lewis Brisbois
- Schneider Wallace
- Rule Garza
- Rosca Scarlato
- McCracken Stemerman
- Wisner Baum
- Manatt Phelps
- George Feldman
- Bailey Duquette
- Ballard Spahr
- Calcaterra Pollack
- Debevoise & Plimpton
- Pashman Stein
- Francis Mailman
- DiCello Levitt
- O'Melveny & Myers
- Nussbaum Law Group
- Bailey & Glasser
- Weil Gotshal
- Gibson Dunn
- Reed Smith
- Lieff Cabraser
- Barnes & Thornburg
- Kaplan Fox
- Polsinelli PC
- Wilson Sonsini
- Marks O'Neill
- Butler Reichline
- Dugan Law Firm
- Shapiro Arato
- Langer Grogan
- Law Offices of Francis O. Scarpulla
- Petrillo Klein
- Hausfeld LLP
- Kralowec Law
- Furth Salem
- Hangley Aronchick
- Pullman & Comley
- Dilworth Paxson
- Yarborough Law Firm
- Bartlit Beck
- Wolf Haldenstein
- Tarter Krinsky
- Cotchett Pitre
- Paul Weiss
- Lowey Dannenberg
- Steven Williams Law
- Taus Cebulash
- Bingham McCutchen
- Dechert LLP
- Seward & Kissel
- Hughes Hubbard
- Simpson Thacher & Bartlett LLP
- Miller & Chevalier
- Lite DePalma
- Berman Tabacco
- Boies Schiller
- Radice Law Firm
- Whatley Kallas
- Cohen Milstein
- Proskauer Rose
- O鈥橬eill & Borges
- Sperling Kenny
- Clark Hill
- Miller Shah
- Zimmerman Reed
- Berger Montague
- Susman Godfrey
- Glancy Prongay
- Alston & Bird
- Gordon Rees
- Constantine Cannon
- Harris St. Laurent
- Shipman & Goodwin
- Fine Kaplan
- Grant & Eisenhofer
- Labaton Keller
- Haug Partners
- Saveri & Saveri
- Curtis Mallet-Prevost
- Latham & Watkins
Companies
- Sun Pharmaceutical Industries Ltd.
- J.M. Smith Corp.
- Perrigo Co. PLC
- Humana Inc.
- Impax Laboratories, Inc.
- McKesson Corp.
- Blue Cross Blue Shield Association
- MSP Recovery
- Walgreens Boots Alliance Inc.
- Endo International PLC
- Bausch Health Cos. Inc.
- Sandoz International GmbH
- Cencora Inc.
- Aurobindo Pharma Ltd.
- Dr. Reddy's Laboratories Ltd.
- Walmart Inc.
- The Harvard Drug Group LLC
- Lupin Ltd.
- Amneal Pharmaceuticals Inc.
- Lannett Company, Inc
- Health Care Service Corp.
- Glenmark Pharmaceuticals Ltd.
- Taro Pharmaceutical Industries Ltd.
- Bi-Lo
- The Cigna Group
- Albertsons Cos. Inc.
- Hi-Tech Pharmacal Co., Inc.
- Red Oak Sourcing LLC
- Molina Healthcare Inc.
- Allergan PLC
- Par Pharmaceutical Cos. Inc.
- Fougera Pharmaceuticals Inc.
- United Food & Commercial Workers International Union
- Alvogen Group Inc.
- West-Ward Pharmaceutical Corp.
- Cadila Pharmaceuticals Ltd.
- Ascend Laboratories LLC
- Emcure Pharmaceuticals Ltd.
- Florida Blue
- Viatris Inc.
- Aetna Inc.
- Akorn Inc.
- Cardinal Health Inc.
- Avet Pharmaceuticals Inc.
- Camber Pharmaceuticals Inc.
- Zydus Pharmaceuticals Inc.
- International Union Of Operating Engineers
- Centene Corp.
- G&W Laboratories Inc.
- The Kroger Co.
- Upsher-Smith Laboratories Inc.
- Rite Aid Corp.
- Winn-Dixie Stores, Inc.
- Wockhardt Ltd.
- Wockhardt USA LLC
- Pfizer Inc.
- Jubilant Cadista
- Novartis AG
- American Federation of State County & Municipal Employees
- Teva Pharmaceutical Industries Ltd.
Government Agencies
Sectors & Industries:
-
May 07, 2021
Dermatology Case Tapped As Bellwether In Generic Drug MDL
A Pennsylvania federal judge has selected a case from state enforcers over dermatology treatments to serve as a bellwether in the multidistrict litigation over price-fixing in the generic-drug industry.
-
May 05, 2021
Generic-Drug Makers Knock States' Objection To Sanctions
Generic-drug makers accused of participating in an industrywide price-fixing scheme are urging a Pennsylvania federal court to disregard state enforcers' objections to a special master's recommendation to sanction the California attorney general's office for failing to fulfill discovery obligations in the multidistrict litigation.
-
April 27, 2021
AGs Warn Against Sanctioning Calif. In Generics Pricing MDL
The attorneys general of Pennsylvania, Oregon and Minnesota urged a Pennsylvania federal judge to reject a special master's recommendation to sanction the California Attorney General's Office for failing to fulfill discovery obligations in multidistrict litigation over inflated medication prices, arguing that it has broad implications.
-
April 07, 2021
States Too Late To Question Report In MDL, Drugmakers Say
A coalition of generic-drug companies filed an opposition brief on Wednesday blasting a group of state attorneys general for contesting a special master's recommendation in sprawling multidistrict litigation accusing much of the generic-drug industry of price-fixing, arguing that the states' motion is untimely.
-
April 06, 2021
Calif. AG Says Sanctions Rec. 'Misunderstands' Generics MDL
The California Attorney General's Office said a聽special master went too far in recommending sanctions against it for not living up to discovery obligations in a multidistrict litigation that accuses much of the generic-drug industry of price-fixing, saying Monday all the material is coming from the defendant drugmakers and third parties.
-
March 30, 2021
Generics Cos. Argue For Heritage Bellwether In Antitrust MDL
A group of generic-drug makers facing multiple antitrust complaints for allegedly working in concert to inflate medication prices has urged a Pennsylvania federal judge to choose a case against Heritage Pharmaceuticals as the bellwether.
-
March 23, 2021
Generics MDL Special Master Says Calif. AG Merits Sanctions
A special master on Monday recommended that the California Attorney General's Office be sanctioned for failing to live up to discovery promises in the sprawling multidistrict litigation that accuses much of the generic drug industry of price-fixing, saying the office should be limited to only evidence that was produced on deadline.
-
March 17, 2021
States Push New Bellwether Generic Drug Price-Fixing Case
If a Pennsylvania federal judge wants to swap out the bellwether case in sprawling litigation that accuses much of the generic drug industry of price-fixing, a coalition of attorneys general want her to choose a different state-brought case than the one聽she's currently considering as a replacement.
-
March 02, 2021
Teva, Mylan Back Plan For New Bellwether In Price-Fix MDL
Mylan, Teva and Par Pharmaceuticals are among a group of generic-drug makers that told a Pennsylvania federal judge Monday they're fine with her plan to swap out a bellwether case in multidistrict litigation that accuses most of the generics industry of price-fixing.
-
February 09, 2021
Teva-Centric Price-Fix Case Likely To Lose Bellwether Status
A Pennsylvania federal judge said Tuesday she was "no longer convinced" that a price-fixing lawsuit centered around Teva from state attorneys general should serve as a bellwether trial for multidistrict litigation accusing most of the generic-drug industry of price-fixing, thanks to related criminal charges against the company.